Changeflow GovPing Healthcare & Life Sciences ECORE Medical Devices Trademark Application
Routine Notice Added Final

ECORE Medical Devices Trademark Application

Favicon for changeflow.com USPTO Trademarks - Medical Devices (Class 010)
Published
Detected
Email

Summary

The USPTO has published a trademark application for 'ECORE' filed by a medical device company. The application covers devices for blocking blood flow, preventing embolization reflux, and use in endovascular and embolization procedures.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published a trademark application (TM79418376) for the mark 'ECORE'. The application, filed on January 30, 2025, and published for opposition on March 26, 2026, pertains to medical devices. Specifically, the goods listed include devices for blocking blood flow, preventing embolization reflux, and for use in endovascular procedures, as well as various types of medical and surgical implants comprised of artificial materials for these purposes.

This publication signifies the application's progression in the trademark registration process. While this is not a regulatory rule or enforcement action, it is relevant for companies operating in the medical device sector to be aware of new brand filings. Companies should monitor this application for any potential oppositions and consider their own intellectual property strategies in this space. No immediate compliance actions are required for other entities based on this trademark publication.

Archived snapshot

Mar 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

ECORE

Published for Opposition TM79418376 Kind: published Mar 26, 2026

Abstract

Medical devices for blocking blood flow, preventing embolization reflux and for use in endovascular procedures; surgical bypass devices comprised of devices to block blood flow and prevent embolization reflux; medical implants, namely, devices to block blood flow and prevent embolization reflux comprised of artificial materials; surgical implants, namely, devices to block blood flow and prevent embolization reflux comprised of artificial materials; surgical implants for use in embolization procedures in peripheral vascular veins or arteries to stop or restrict blood flow comprised of artificial materials

Filing Date

2025-01-30

View original document →

Get daily alerts for USPTO Trademarks - Medical Devices (Class 010)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79418376

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Manufacturing Endovascular Procedures
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Legal
Topics
Intellectual Property Product Safety

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Devices (Class 010) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!